The knockdown of RARS-MAD1L1 reduced the growth and colony formation of cancer cells in vitro, indicating that RARS-MAD1L1 inhibition might be a new strategy for cancer treatment (Zhong et al., 2018). Here, RARS1 is linked to cancer.